PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.597
https://www.valueinhealthjournal.com/article/S1098-3015(19)32975-4/fulltext
Title :
PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32975-4&doi=10.1016/j.jval.2019.09.597
First page :
Section Title :
Open access? :
No
Section Order :
10510